Health Canada has put forth specific guidelines for clinical sponsors for the management of clinical trials during the COVID-19 pandemic. These are stressful times for many but we are ensuring...
Read More
You start to feel a tickle in the back of your throat. It turns into a full-blown cough. Then you develop a fever. You shake and get chills as you...
Read More
Coronavirus is the topic on many peoples’ minds right now as the number of cases continue to climb. Multiple companies are working hard to develop and test a vaccine for...
Read More
Bay Area Research Logistics (BARL) would like to assure our clients that product quality and patient safety is of the utmost importance to our company and our employees. The development...
Read More
The success of a clinical trial often depends on attracting the appropriate participants so that the sample reflects the general population. But how to ensure that this is the case? We’ve found some of the major problems with clinical trial diversity and how to solve them. Who is Represented? Studies indicate that many trials under-represent women, people of colour, and…
2019 was an exciting year for the clinical trial and medical community with some major breakthroughs and news. Here are the top 5 groundbreaking happenings that caught our attention this...
Read More
Clinical trial logistics is hard. Finding a supply chain solution that is right for your company, as well as qualified personnel to handle it, can be a challenge. To make sure...
Read More
The USA Orphan Drug Act of 1983 created incentives for pharmaceutical companies to research and create new drug therapies for rare diseases. These incentives include tax breaks, exclusive marketing rights, unique research grants and fast-tracked FDA review processes. As a result, the clinical costs associated with the development of an orphan drug are less than those associated with non-orphan drugs1….
Clinical trials are fundamental to testing new medicine, investigating existing medicine and improving healthcare. Most research protocols are either designed by researchers employed by the pharmaceutical/ medical device company or investigators from academic institutions. Here are six things that distinguish industry clinical trials from academic clinical trials: Funding – Industry-initiated clinical trials are financially supported by the industry. The primary…
Study non-adherence is an ongoing problem surrounding clinical trials. Noncompliance drives up research costs and increases the time it takes new medicines to make it to the market. One study suggests that costs associated with noncompliance are as high as $1.5 billion by the time the investigational product (IP) is fully developed 1. Considerate IP packaging is one way researchers…
